Clinical Trials
3 trialsNCT01188499 2016-05-30
Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors
TetraLogic Pharmaceuticals
Phase 1/2 Completed
NCT00993239 2016-03-03
Dose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma
TetraLogic Pharmaceuticals
Phase 1 Completed
NCT01940172 2016-01-14
Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer
TetraLogic Pharmaceuticals
Phase 1 Completed